AI 활용 X선 솔루션 시장 : 세계 및 지역별 분석 - 제품, 워크플로우, 배포 모델, 치료 용도, 지역별 - 분석 및 예측(2026-2036년)

This report can be delivered within 1 working day.

Introduction of the AI-Enabled X-ray Solutions Market

The global AI-enabled X-ray solutions market, initially valued at $382.4 million in 2024, is projected to witness substantial growth, reaching $3,332.5 million by 2036, marking a remarkable compound annual growth rate (CAGR) of 19.88% over the period from 2026 to 2036.

The global AI-enabled X-ray solutions market is witnessing robust growth, driven by the increasing demand for faster, more accurate, and scalable diagnostic imaging amid rising patient volumes and persistent radiology workforce shortages. X-ray imaging remains one of the most widely used and first-line diagnostic modalities across healthcare systems, particularly in emergency care, primary diagnosis, and screening programs. The integration of artificial intelligence (AI)/machine learning (ML) into X-ray workflows is transforming conventional radiography by enabling automated image acquisition, real-time quality control, abnormality detection, and decision support. AI-enabled X-ray solutions are particularly valuable in high-volume settings such as chest imaging, trauma care, and tuberculosis (TB) screening, where rapid triage and prioritization are critical. As healthcare systems shift toward value-based care and operational efficiency, the adoption of AI in X-ray imaging is accelerating to reduce reporting turnaround times, improve diagnostic consistency, and optimize resource utilization.

Technological advancements in deep learning and computer vision are significantly enhancing the capabilities of AI-enabled X-ray systems. Innovations such as automated patient positioning, intelligent exposure optimization, bone suppression, and AI-assisted reporting are improving both image quality and clinical outcomes. In addition, the emergence of cloud- and web-based AI platforms is enabling scalable deployment across multi-site healthcare networks, facilitating seamless integration with existing radiology IT infrastructure, including PACS and RIS systems. The growing emphasis on enterprise imaging and AI orchestration platforms is further driving the transition from standalone algorithms to integrated, workflow-centric solutions. However, the market continues to face challenges, including data privacy concerns, regulatory complexities, interoperability issues, and the need for clinical validation across diverse populations. Despite these challenges, increasing investments in AI research, expanding public health screening initiatives, and strategic collaborations between imaging vendors and AI developers are expected to drive sustained growth and innovation in the AI-enabled X-ray solutions market.

Market Introduction

The global AI-enabled X-ray solutions market has undergone a notable transformation, driven by the rapid adoption of advanced artificial intelligence technologies and increasing strategic collaborations between imaging vendors, AI developers, and healthcare providers. Companies are progressively embedding deep learning and computer vision algorithms into X-ray systems to enhance the speed, accuracy, and consistency of image interpretation and workflow management. These solutions span a wide range of applications, including automated abnormality detection, AI-assisted triage, image quality optimization, and clinical decision support, enabling more efficient and standardized radiology practices.

Key advancements, such as multi-pathology detection algorithms, AI-driven workflow orchestration platforms, and integration with enterprise imaging systems, underscore the industry's focus on improving diagnostic performance and operational efficiency. The growing incorporation of AI into both fixed and mobile X-ray systems is further expanding access to timely diagnostics, particularly in emergency care and large-scale screening programs such as chest imaging and TB detection. As imaging volumes continue to rise and healthcare systems increasingly prioritize faster turnaround times and improved diagnostic accuracy, ongoing innovations in AI-enabled X-ray solutions are expected to shape the market's trajectory, positioning these technologies as integral to modern radiography workflows and patient management pathways in the overall AI-enabled medical imaging solutions domain.

Industrial Impact

The global AI-enabled X-ray solutions market has witnessed substantial growth, driven by the increasing demand for efficient, scalable, and high-accuracy diagnostic imaging solutions, along with the rising need to address radiology workforce shortages and growing imaging volumes. Key players such as Agfa-Gevaert Group, Carestream Health Inc., FUJIFILM Holdings Corporation, General Electric Company, Koninklijke Philips N.V., and Siemens Healthineers AG are playing a pivotal role in advancing AI-driven radiography technologies. These companies are actively developing and integrating AI capabilities across X-ray workflows, including image acquisition optimization, automated abnormality detection, triage, and AI-assisted reporting. These innovations are particularly impactful in high-burden clinical areas such as chest imaging, musculoskeletal diagnostics, trauma assessment, and infectious disease screening (e.g., tuberculosis), where rapid and accurate interpretation is critical. AI-enabled X-ray solutions are enhancing diagnostic consistency, reducing reporting turnaround times, and improving clinical outcomes by enabling earlier and more precise detection of abnormalities. Additionally, the integration of AI into mobile and portable X-ray systems is expanding access to imaging in emergency settings, intensive care units, and resource-limited environments.

Market Segmentation:

Segmentation 1: By Product

• Hardware
• Software

Software Segment to Dominate the AI-Enabled X-ray Solutions Market (by Product)

In terms of product, the software segment is expected to lead the AI-enabled X-ray solutions market, accounting for a significant share due to the increasing reliance on AI-driven applications for image interpretation, workflow optimization, and clinical decision support. AI software solutions are central to enabling functionalities such as automated abnormality detection, triage and prioritization, structured reporting, and predictive analytics, making them indispensable across modern radiology workflows.

Segmentation 2: By Workflow

• Image Acquisition
• Image Analysis
• Detection
• Diagnosis and Treatment Decision Support
• Predictive Analysis and Risk Assessment
• Triage
• Reporting and Communication

Image Analysis to Dominate the AI-Enabled X-ray Solutions Market (by Workflow)

In terms of workflow, image analysis is expected to lead the global AI-enabled X-ray solutions market, driven by its central role in extracting clinically meaningful insights from radiographic images and enabling downstream diagnostic decision-making. AI-powered image analysis solutions are widely adopted to automate tasks such as anatomical recognition, abnormality identification, segmentation, and quantitative measurements, significantly improving diagnostic accuracy and consistency across radiology practices. As imaging volumes continue to rise, particularly in high-frequency applications such as chest X-rays, trauma imaging, and screening programs, the need for efficient and standardized image interpretation is becoming increasingly critical. AI-based image analysis tools help reduce variability in readings, support radiologists in detecting subtle findings, and enhance overall workflow efficiency by enabling faster and more reliable interpretation of images.

Segmentation 3: By Deployment Model

• Cloud- and Web-Based Solutions
• On-Premise Solutions

Cloud- and Web-Based Solutions to Dominate the AI-Enabled X-ray Solutions Market (by Deployment Model)

In terms of deployment model, cloud- and web-based solutions are expected to lead the global AI-enabled X-ray solutions market, growing at a CAGR of 20.98%, driven by their scalability, flexibility, and ability to support enterprise-wide AI integration. These solutions enable healthcare providers to deploy AI applications across multiple sites without the need for extensive on-premises infrastructure, making them particularly attractive for large hospital networks, teleradiology providers, and screening programs. Cloud-based platforms facilitate centralized data storage, real-time image processing, and seamless access to AI algorithms, allowing radiologists and clinicians to collaborate more effectively and access diagnostic insights from any location. This is especially valuable in high-volume environments and geographically dispersed healthcare systems, where rapid image sharing and remote interpretation are critical.

Segmentation 4: By Therapeutic Application

• General Radiology
• Specialty Radiology

General Radiology to Dominate the AI-Enabled X-ray Solutions Market (by Therapeutic Application)

In terms of therapeutic application, general radiology is expected to lead the global AI-enabled X-ray solutions market, driven by the high volume and broad clinical utility of routine radiographic procedures across healthcare settings. The extensive use of X-ray imaging as a first-line diagnostic tool in emergency departments, outpatient settings, and primary care significantly contributes to the dominance of this segment. The integration of AI into general radiology workflows is enhancing efficiency and diagnostic accuracy by enabling automated abnormality detection, image quality optimization, and prioritization of critical cases.

Segmentation 5: By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe
• Asia-Pacific
  • China
  • Japan
  • Australia and New Zealand
  • Rest-of-Asia-Pacific
• Rest-of-the-World

North America to Dominate the AI-Enabled X-ray Solutions Market (by Region)

North America is expected to lead the global AI-enabled X-ray solutions market, driven by its advanced healthcare infrastructure, high adoption of digital imaging technologies, and strong presence of leading imaging OEMs and AI solution providers. The region benefits from widespread integration of electronic health records (EHRs), PACS, and RIS systems, which facilitates seamless deployment and scaling of AI-enabled radiography solutions across hospitals and imaging centers.

Recent Developments in the AI-Enabled X-ray Solutions Market

• In March 2026, RadNet, Inc. announced that its subsidiary DeepHealth, Inc. acquired Gleamer to expand its global portfolio of clinical AI solutions for radiology across modalities, including CT, MR, X-ray, mammography, and ultrasound. The acquisition strengthens DeepHealth, Inc.'s AI-powered imaging interpretation and workflow solutions and positions it as one of the largest providers of radiology clinical AI technologies worldwide.
• In January 2026, FUJIFILM Holdings Corporation introduced a new portfolio of CT, mammography, X-ray, and healthcare IT solutions integrated with AI-enabled medical imaging and workflow automation, enabling end-to-end diagnostic workflows, faster clinical decision-making, and improved radiology efficiency across India.
• In October 2025, Carestream Health Inc. announced an update to its Image Suite V4 Software (MR 11), introducing AI-enabled image processing features such as bone suppression and pneumothorax visualization to enhance diagnostic accuracy. The update also improves workflow efficiency and user experience across computed and digital radiography systems.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Need for Faster Triage of Urgent Chest X-ray Findings in Emergency and Critical Care Pathways Driving the Adoption of AI-Enabled X-ray Solutions: Emergency and critical care environments are accelerating the adoption of AI-enabled X-ray solutions, as radiography is a primary imaging modality for trauma and acute chest conditions where speed and accuracy are critical. AI-driven triage tools enable rapid identification and prioritization of urgent findings, helping reduce interpretation delays, minimize diagnostic errors, and improve patient throughput. Evidence from real-world and simulated studies indicates that AI can lower discrepancy rates, shorten emergency department length of stay, and significantly reduce radiologist workload while maintaining diagnostic performance. Additionally, evolving policy support reinforces the clinical and operational value of these solutions. With increasing integration into PACS, radiology worklists, and X-ray systems, AI-enabled triage is becoming a key enabler of faster turnaround times and more responsive care in high-acuity settings.

Market Challenges:

Human Factor Risks, including Overreliance, False Positives, Deskilling, and Uncertain Impact on Radiologist Workload: AI-enabled X-ray solutions, while designed to support clinical decision-making, introduce several human-factor risks that can influence adoption and real-world effectiveness. AI-assisted tools can shape reading behavior by directing attention toward flagged findings, potentially increasing the risk of overlooking non-target abnormalities or altering diagnostic thresholds, particularly in high-volume and time-sensitive environments such as emergency care. Overreliance on AI outputs and the potential for clinician deskilling remain key concerns, while false positives may lead to additional imaging, increased referrals, and cautious decision-making that can offset efficiency gains. Furthermore, the impact of AI on radiologists' workload remains uncertain, with mixed perceptions regarding whether these tools reduce or increase reporting burden. Ensuring appropriate use, consistent training, and balanced human-AI interaction is challenging across clinical settings, and these factors collectively introduce operational complexities that may affect user trust, workflow efficiency, and overall value realization of AI-enabled X-ray solutions.

Market Opportunities:

Extending AI-Enabled X-ray into Legacy, Low-Resource, and Non-Digital Imaging Environments: A significant growth opportunity in the AI-enabled X-ray solutions market lies in expanding deployment beyond fully digital, PACS-integrated environments to include legacy and low-resource settings that rely on film-based or minimally digitized imaging infrastructure. A large portion of the global X-ray installed base, particularly in tuberculosis-endemic regions and low- and middle-income countries, operates with limited connectivity and non-DICOM workflows, creating a substantial untapped market for adaptable AI solutions. Vendors capable of supporting alternative image ingestion methods, such as photographed films, hybrid analog-digital workflows, and lightweight formats, are well-positioned to enable adoption in decentralized screening programs, mobile diagnostic units, and resource-constrained facilities. Emerging evidence supports the feasibility of such approaches, demonstrating that AI performance can be maintained even when applied to non-standard image formats.

How can this report add value to an organization?

Product/Innovation Strategy: The global AI-enabled X-ray solutions market has been divided into several key segments, including product, workflow, deployment model, therapeutic application, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the AI-enabled X-ray solutions market. Companies are increasingly collaborating with healthcare providers, AI developers, and imaging IT vendors to enable seamless integration of AI into clinical workflows.

Competitive Strategy: The AI-enabled X-ray solutions market is highly competitive, with numerous well-established players offering a range of solutions. Key players are focusing on continuous innovation in AI algorithms, regulatory approvals, and integration capabilities to differentiate their offerings.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Years from 2024 to 2036 have been considered for the global market size estimation, 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
• The scope of the report is based on comprehensive inputs from industry experts across various sectors, including specialty clinics and hospitals, diagnostic laboratories, imaging centers, reference laboratories, and research institutions.
• The market contribution of AI-enabled X-ray solutions is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
• Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
• The market has been mapped based on the existing AI-enabled X-ray software and hardware. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and X-ray ecosystem, including AI-enabled X-ray solution providers, digital radiography system manufacturers, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, imaging centers, screening programs, and teleradiology providers have been consulted to validate adoption trends, workflow integration, and clinical utility specific to X-ray imaging. Respondents, including CEOs, vice presidents, product and marketing directors, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of report segmentations and key qualitative findings
• understanding the competitive landscape and business model
• current and proposed production values of a product by market players
• validation of the numbers of different segments of the market in focus
• percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investors' presentations of the leading market players
• Company websites and a detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players in the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Agfa-Gevaert Group
• Carestream Health Inc.
• DeepTek.ai, Inc
• FUJIFILM Holdings Corporation
• General Electric Company
• Imagen Technologies
• Infervision Medical Technology Co., Ltd.
• Konica Minolta, Inc.
• Koninklijke Philips N.V.
• Lunit Inc.
• Qure.ai
• RadNet, Inc. (DeepHealth, Inc.)
• Siemens Healthineers AG
• Tempus AI
• VUNO, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Global AI-Enabled X-ray Solutions Market: Industry Outlook

• 1.1 Market Overview
• 1.2 Market Trends
  • 1.2.1 Impact Analysis
    • 1.2.1.1 Emerging shift toward platform-based consolidation and portfolio expansion in X-ray AI
    • 1.2.1.2 Generative AI and structured-reporting support are becoming part of routine radiography workflows
• 1.3 Regulatory Framework
  • 1.3.1 Consortiums, Associations, and Regulatory Bodies
  • 1.3.2 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
  • 1.3.3 Regulatory Framework in North America
    • 1.3.3.1 Regulatory Framework in the U.S.
  • 1.3.4 Regulatory Framework in Europe
  • 1.3.5 Regulatory Framework in Asia-Pacific
    • 1.3.5.1 Regulatory Framework in Japan
    • 1.3.5.2 Regulatory Framework in China
    • 1.3.5.3 Regulatory Framework in India
  • 1.3.6 Regulatory Framework in the Other Countries
    • 1.3.6.1 Regulatory Framework in Brazil
    • 1.3.6.2 Regulatory Framework in Mexico
    • 1.3.6.3 Regulatory Framework in Israel
    • 1.3.6.4 Regulatory Framework in the K.S.A.
    • 1.3.6.5 Regulatory Framework in the U.A.E.
• 1.4 Value Chain Analysis
  • 1.4.1 Key Stages in Value Chain
  • 1.4.2 Key Challenges across the Value Chain
  • 1.4.3 Strategic Implications for Stakeholders
• 1.5 Market Dynamics
  • 1.5.1 Market Drivers
    • 1.5.1.1 Radiology Workforce Shortages and Reporting Backlogs Driving Demand for X-Ray AI Triage and Reporting Support
    • 1.5.1.2 Need for Faster Triage of Urgent Chest X-ray Findings in Emergency and Critical Care Pathways Driving Adoption of AI-Enabled X-ray Solutions
    • 1.5.1.3 Tuberculosis Screening and Public Health Surveillance Expanding the Addressable Market for AI-Enabled Chest X-Ray
  • 1.5.2 Market Challenges
    • 1.5.2.1 Human Factor Risks, Including Overreliance, False Positives, Deskilling, and Uncertain Impact on Radiologist Workload
    • 1.5.2.2 Limited Real-World Outcomes and Cost-Effectiveness Evidence Slowing Broader Procurement and Reimbursement
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Extending AI-Enabled X-ray into Legacy, Low-Resource, and Non-Digital Imaging Environments
    • 1.5.3.2 Using X-ray Foundation Models to Broaden Product Portfolios Beyond Single-Use Algorithms

2 Global AI-Enabled X-ray Solutions Market (by Product), $Million, 2024-2036

• 2.1 Software
  • 2.1.1 Overview
  • 2.1.2 Market Sizing and Forecast
• 2.2 Hardware
  • 2.2.1 Overview
  • 2.2.2 Market Sizing and Forecast

3 Global AI-Enabled X-ray Solutions Market (by Workflow), $Million, 2024-2036

• 3.1 Image Acquisition
  • 3.1.1 Overview
  • 3.1.2 Market Sizing and Forecast
• 3.2 Image Analysis
  • 3.2.1 Overview
  • 3.2.2 Market Sizing and Forecast
• 3.3 Detection
  • 3.3.1 Overview
  • 3.3.2 Market Sizing and Forecast
• 3.4 Diagnosis and Treatment Decision Support
  • 3.4.1 Overview
  • 3.4.2 Market Sizing and Forecast
• 3.5 Predictive Analysis and Risk Assessment
  • 3.5.1 Overview
  • 3.5.2 Market Sizing and Forecast
• 3.6 Triage
  • 3.6.1 Overview
  • 3.6.2 Market Sizing and Forecast
• 3.7 Reporting and Communication
  • 3.7.1 Overview
  • 3.7.2 Market Sizing and Forecast

4 Global AI-Enabled X-ray Solutions Market (by Deployment Model), $Million, 2024-2036

• 4.1 Cloud- and Web-Based Solutions
  • 4.1.1 Overview
  • 4.1.2 Market Sizing and Forecast
• 4.2 On-Premises Solutions
  • 4.2.1 Overview
  • 4.2.2 Market Sizing and Forecast

5 Global AI-Enabled X-ray Solutions Market (by Therapeutic Application), $Million, 2024-2036

• 5.1 General Radiology
  • 5.1.1 Overview
  • 5.1.2 Market Sizing and Forecast
• 5.2 Specialty Radiology
  • 5.2.1 Overview
  • 5.2.2 Market Sizing and Forecast

6 Global AI-Enabled X-ray Solutions Market (by Region), $Million, 2024-2036

• 6.1 Regional Summary
• 6.2 North America
  • 6.2.1 Regional Overview
  • 6.2.2 Driving Factors for Market Growth
  • 6.2.3 Factors Challenging the Market
  • 6.2.4 Analyst View
  • 6.2.5 Market Sizing and Forecast
    • 6.2.5.1 North America AI-Enabled X-ray Solutions Market, by Country
      • 6.2.5.1.1 U.S.
      • 6.2.5.1.2 Canada
• 6.3 Europe
  • 6.3.1 Regional Overview
  • 6.3.2 Driving Factors for Market Growth
  • 6.3.3 Factors Challenging the Market
  • 6.3.4 Analyst View
  • 6.3.5 Market Sizing and Forecast
    • 6.3.5.1 Europe AI-Enabled X-ray Solutions Market, by Country
      • 6.3.5.1.1 U.K.
      • 6.3.5.1.2 Germany
      • 6.3.5.1.3 France
      • 6.3.5.1.4 Italy
      • 6.3.5.1.5 Spain
      • 6.3.5.1.6 Rest-of-Europe
• 6.4 Asia-Pacific
  • 6.4.1 Regional Overview
  • 6.4.2 Driving Factors for Market Growth
  • 6.4.3 Factors Challenging the Market
  • 6.4.4 Analyst View
  • 6.4.5 Market Sizing and Forecast
    • 6.4.5.1 Asia-Pacific AI-Enabled X-ray Solutions Market, by Country
      • 6.4.5.1.1 China
      • 6.4.5.1.2 Japan
      • 6.4.5.1.3 Australia and New Zealand
      • 6.4.5.1.4 Rest-of-Asia-Pacific
• 6.5 Rest-of-the-World
  • 6.5.1 Regional Overview
  • 6.5.2 Driving Factors for Market Growth
  • 6.5.3 Factors Challenging the Market
  • 6.5.4 Analyst View
  • 6.5.5 Market Sizing and Forecast

7 Competitive Benchmarking and Company Profiles

• 7.1 Key Strategies and Developments, January 2023-March 2026
• 7.2 Key Developments Analysis (by Company)
• 7.3 Company Profiles
  • 7.3.1 Agfa-Gevaert Group
    • 7.3.1.1 Overview
    • 7.3.1.2 Top Products/Product Portfolio
    • 7.3.1.3 Top Competitors
    • 7.3.1.4 Target Customers
    • 7.3.1.5 Key Personnel
    • 7.3.1.6 Analyst View
  • 7.3.2 Carestream Health Inc.
    • 7.3.2.1 Overview
    • 7.3.2.2 Top Products/Product Portfolio
    • 7.3.2.3 Top Competitors
    • 7.3.2.4 Target Customers
    • 7.3.2.5 Key Personnel
    • 7.3.2.6 Analyst View
  • 7.3.3 DeepTek.ai, Inc
    • 7.3.3.1 Overview
    • 7.3.3.2 Top Products/Product Portfolio
    • 7.3.3.3 Top Competitors
    • 7.3.3.4 Target Customers
    • 7.3.3.5 Key Personnel
    • 7.3.3.6 Analyst View
  • 7.3.4 FUJIFILM Holdings Corporation
    • 7.3.4.1 Overview
    • 7.3.4.2 Top Products/Product Portfolio
    • 7.3.4.3 Top Competitors
    • 7.3.4.4 Target Customers
    • 7.3.4.5 Key Personnel
    • 7.3.4.6 Analyst View
  • 7.3.5 General Electric Company
    • 7.3.5.1 Overview
    • 7.3.5.2 Top Products/Product Portfolio
    • 7.3.5.3 Top Competitors
    • 7.3.5.4 Target Customers
    • 7.3.5.5 Key Personnel
    • 7.3.5.6 Analyst View
  • 7.3.6 Imagen Technologies
    • 7.3.6.1 Overview
    • 7.3.6.2 Top Products/Product Portfolio
    • 7.3.6.3 Top Competitors
    • 7.3.6.4 Target Customers
    • 7.3.6.5 Key Personnel
    • 7.3.6.6 Analyst View
  • 7.3.7 Infervision Medical Technology Co., Ltd.
    • 7.3.7.1 Overview
    • 7.3.7.2 Top Products/Product Portfolio
    • 7.3.7.3 Top Competitors
    • 7.3.7.4 Target Customers
    • 7.3.7.5 Key Personnel
    • 7.3.7.6 Analyst View
  • 7.3.8 Konica Minolta, Inc.
    • 7.3.8.1 Overview
    • 7.3.8.2 Top Products/Product Portfolio
    • 7.3.8.3 Top Competitors
    • 7.3.8.4 Target Customers
    • 7.3.8.5 Key Personnel
    • 7.3.8.6 Analyst View
  • 7.3.9 Koninklijke Philips N.V.
    • 7.3.9.1 Overview
    • 7.3.9.2 Top Products/Product Portfolio
    • 7.3.9.3 Top Competitors
    • 7.3.9.4 Target Customers
    • 7.3.9.5 Key Personnel
    • 7.3.9.6 Analyst View
  • 7.3.10 Lunit Inc.
    • 7.3.10.1 Overview
    • 7.3.10.2 Top Products/Product Portfolio
    • 7.3.10.3 Top Competitors
    • 7.3.10.4 Target Customers
    • 7.3.10.5 Key Personnel
    • 7.3.10.6 Analyst View
  • 7.3.11 Qure.ai
    • 7.3.11.1 Overview
    • 7.3.11.2 Top Products/Product Portfolio
    • 7.3.11.3 Top Competitors
    • 7.3.11.4 Target Customers
    • 7.3.11.5 Key Personnel
    • 7.3.11.6 Analyst View
  • 7.3.12 RadNet, Inc. (DeepHealth, Inc.)
    • 7.3.12.1 Overview
    • 7.3.12.2 Top Products/Product Portfolio
    • 7.3.12.3 Top Competitors
    • 7.3.12.4 Target Customers
    • 7.3.12.5 Key Personnel
    • 7.3.12.6 Analyst View
  • 7.3.13 Siemens Healthineers AG
    • 7.3.13.1 Overview
    • 7.3.13.2 Top Products/Product Portfolio
    • 7.3.13.3 Top Competitors
    • 7.3.13.4 Target Customers
    • 7.3.13.5 Key Personnel
    • 7.3.13.6 Analyst View
  • 7.3.14 Tempus AI
    • 7.3.14.1 Overview
    • 7.3.14.2 Top Products/Product Portfolio
    • 7.3.14.3 Top Competitors
    • 7.3.14.4 Target Customers
    • 7.3.14.5 Key Personnel
    • 7.3.14.6 Analyst View
  • 7.3.15 VUNO, Inc.
    • 7.3.15.1 Overview
    • 7.3.15.2 Top Products/Product Portfolio
    • 7.3.15.3 Top Competitors
    • 7.3.15.4 Target Customers
    • 7.3.15.5 Key Personnel
    • 7.3.15.6 Analyst View

8 Research Methodology

• 8.1 Data Sources
  • 8.1.1 Primary Data Sources
  • 8.1.2 Secondary Data Sources
  • 8.1.3 Data Triangulation
• 8.2 Market Estimation and Forecast